Disc Medicine (IRON) Total Liabilities (2020 - 2026)
Disc Medicine (IRON) posted quarterly Total Liabilities of $90.9 million for Q2 2026, up 78.61% year-over-year from $50.9 million in Q2 2025, and up 47.14% quarter-over-quarter from $61.8 million in Q1 2026.
Analysis
Disc Medicine (IRON) Total Liabilities (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Total Liabilities for 7 consecutive years, with $90.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Liabilities rose 78.61% year-over-year to $90.9 million; the TTM figure through Jun 2026 stood at $90.9 million (up 78.61% YoY), while the FY2025 annual figure was $67.1 million, up 26.07% from the prior year.
- Total Liabilities climbed to $90.9 million in Q2 2026 per IRON's latest filing, from $61.8 million in the prior quarter.
- Across five years, Total Liabilities topped out at $90.9 million in Q2 2026 and bottomed at $1.5 million in Q3 2022.
- Historically, Total Liabilities has averaged $33.5 million across 5 years, with a median of $23.2 million in 2022.
- Annual changes were most pronounced in 2022 — Total Liabilities tumbled 90.02% — and 2023, when it jumped 1096.93%.
- Disc Medicine's Total Liabilities stood at $23.6 million in 2022, then retreated by 3.09% to $22.9 million in 2023, then soared by 132.51% to $53.2 million in 2024, then grew by 26.07% to $67.1 million in 2025, then surged by 35.57% to $90.9 million in 2026.
- Business Quant data shows IRON's Total Liabilities at $90.9 million in Q2 2026, $61.8 million in Q1 2026, and $67.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 4.20 Bn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | 1.72 Bn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 4.00 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 10.03 Bn |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Disc Medicine | 3.08 Bn | 3.08 Bn | - | 90.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.91 Mn |
| Mar 31, 2026 | 61.78 Mn |
| Dec 31, 2025 | 67.05 Mn |
| Sep 30, 2025 | 57.07 Mn |
| Jun 30, 2025 | 50.90 Mn |
| Mar 31, 2025 | 48.90 Mn |
| Dec 31, 2024 | 53.19 Mn |
| Sep 30, 2024 | 27.19 Mn |
| Jun 30, 2024 | 21.39 Mn |
| Mar 31, 2024 | 16.11 Mn |
| Dec 31, 2023 | 22.88 Mn |
| Sep 30, 2023 | 17.52 Mn |
| Jun 30, 2023 | 12.96 Mn |
| Mar 31, 2023 | 10.93 Mn |
| Dec 31, 2022 | 23.61 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 6.44 Mn |
| Mar 31, 2022 | 12.67 Mn |
| Dec 31, 2021 | 14.76 Mn |
| Sep 30, 2021 | 14.67 Mn |